Healogics® iSupply Program Reaches 100 Enrollments

JACKSONVILLE, Fla., Oct. 10, 2019 /PRNewswire/ — Healogics® Inc., the nation’s largest provider of advanced chronic wound care services, celebrates the 100th enrollment in Healogics® iSupply during National Healthcare Supply Chain Week. The Healogics iSupply program is focused on ensuring hospitals and patients receive the best value from wound care products commonly used in Wound Care Centers® and other sites of care.

The Healogics iSupply program first launched a year ago in Healogics Wound Care Centers as a new innovative solution that aimed to improve quality outcomes as demonstrated through verifiable outcomes data and effective utilization management to reduce unnecessary waste. It includes a comprehensive line of advanced dressings, cellular-based tissue products and total contact cast products, each of which was selected through a rigorous analysis of published data and reviewed by Healogics value analysis committee of leading wound care clinicians.

“Over the past year, we have seen the positive impact iSupply has on our hospital partners and patients,” said David Bassin, Chief Executive Officer at Healogics. “This program provides patients consistency in products and has lowered the cost of patient care for our hospital partners.”

Participants in the Healogics iSupply program include: Integra® LifeSciences, BSN Medical Inc. an Essity company, Solsys Medical™ and Healogics private label advanced dressings, Healogics by DermaRite®. Some of the key features of this unique program include access to market-leading rates on wound care product lines and education on how to minimize unnecessary product waste, resulting in ongoing cost reduction opportunities.

“I am so proud of our Supply Chain team who has worked diligently with our current customers enrolled in the iSupply program,” said Michael White, President, Healogics At Home and iSupply. “We are excited to have reached this milestone of 100 enrollments. We will continue to provide our customers with products that will aid in improving patient care while reducing the cost of care.”

About Healogics

Headquartered in Jacksonville, Fla., Healogics is the nation’s wound healing expert. Last year over 330,000 patients received advanced wound care through a nationwide network of 650 Wound Care Centers®. The Healogics team is made up of nearly 3,000 employees, 4,000 affiliated physicians and a Healogics Specialty Physician practice group of almost 300. In addition to the company’s network of outpatient Centers, Healogics partners with over 300 skilled nursing facilities to care for patients with chronic wounds, and provides inpatient consults at 85 partner hospitals. As the industry leader, Healogics has the largest repository of chronic wound-specific patient data in the country. The Healogics Wound Science Initiative, an effort launched in 2017 to provide peer-reviewed research, recognizes the value and relevance of big data and advanced analytics to drive continuous, collaborative learning towards a better understanding of how to efficiently utilize healthcare resources for patients with wounds. For additional information, please visit Healogics.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/healogics-isupply-program-reaches-100-enrollments-300936850.html

SOURCE Healogics

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

4 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

7 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

7 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

7 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

7 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

7 hours ago